annb0t
Top 20
Recce Pharmaceuticals
Highlights:
10 subjects in cohort six intravenously dosed with RECCE® 327 at 4,000mg demonstrated good safety and tolerability Independent Safety Committee to review cohort six data â anticipate recommendation to proceed Cohort six dosing at 4,000mg completed â an 80-fold increase from cohort one at 50mg
SYDNEY Australia, June 22, 2022 (GLOBE NEWSWIRE) -- Recce Pharmaceuticals Ltd (ASX:RCE, FSE:R9Q) (the Company), the company developing a new class of synth...
>>> Read more: Recce Pharmaceuticals Announces Positive Safety Data from Sixth Cohort of Phase I Clinical Trial Evaluating Healthy Subjects Intravenously Dosed with RECCE® 327
Highlights:
10 subjects in cohort six intravenously dosed with RECCE® 327 at 4,000mg demonstrated good safety and tolerability Independent Safety Committee to review cohort six data â anticipate recommendation to proceed Cohort six dosing at 4,000mg completed â an 80-fold increase from cohort one at 50mg
SYDNEY Australia, June 22, 2022 (GLOBE NEWSWIRE) -- Recce Pharmaceuticals Ltd (ASX:RCE, FSE:R9Q) (the Company), the company developing a new class of synth...
>>> Read more: Recce Pharmaceuticals Announces Positive Safety Data from Sixth Cohort of Phase I Clinical Trial Evaluating Healthy Subjects Intravenously Dosed with RECCE® 327
